US medical company Liminatus Pharma plans to raise $500 million to invest in BNB
2025-07-28 11:43:09
Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical biopharmaceutical company, today announced plans to strategically expand into cryptocurrency and blockchain. The company plans to establish a subsidiary called American BNB Strategy to lead its digital asset investment and management program. Through this platform, Liminatus plans to raise and deploy up to $500 million in funding in phases with the goal of making a strategic long-term investment in BNB.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
美股医疗公司Liminatus Pharma拟筹集部署5亿美元资金投资BNBNext article：
金涌投资宣布 1000 万美元 Web3.0 及虚拟资产投资计划
